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Abstract
O-GlcNAcylation is a post-translational modification which occurs on 
proteins located in the cytosol and nucleus of cells. This modification 
regulates the expression and functions of proteins, thereby participating 
in various cellular signalings and cell mechanisms. UDP-GlcNAc, the 
O-GlcNAc donor of the O-GlcNAcylation is synthesized from glucose via 
hexosamine biosynthetic pathway. Production of UDP-GlcNAc is greatly 
reliant on the cellular glucose condition. It is also known that 
O-GlcNAcylation is involved in numerous diseases such as cancer, 
diabetes, and Alzheimer's disease.
Recent scientific reports showed that cancer cells are in an elevated 
state of O-GlcNAcylation when compared with normal cells and 
furthermore, it was also shown that O-GlcNAcylation is involved in cell 
cycle regulation. From this we hypothesized that higher O-GlcNAcylation 
in cancer cells promotes cell cycle transition. In order to verify this 
hypothesis, we generated an OGT knock-down stable cell line using 
lung cancer cell line A549. Through FACS analysis, we observed a 
relatively delayed G1/S cell cycle transition in these cells. Using Western 
blot, we determined that hypophosphorylation of pRB was the cause of 
the delayed G1/S cycle transition.
To gain a better understanding of the relationship between the 
- 2 -
decrease in O-GlcNAcylation and pRB hypophosphorylation, we 
examined whether cyclin-dependent kinase 4 (Cdk4), a protein crucially 
involved in phosphorylation of pRB, is O-GlcNAcylated. By Western blot, 
we detected the presence of O-GlcNAcylation on overexpressed Cdk4 
and observed an increase in detected O-GlcNAcylation when OGT was 
also overexpressed. Furthermore, using protein O-GlcNAc moiety binding 
sWGA precipitation, we observed O-GlcNAcylation on Cdk4 regulation 
during G1/S cell cycle transition.
To determine the functions of O-GlcNAcylation on Cdk4, we focused 
on Cdk4 and cyclin D binding affinity which is critical to the G1/S 
transition. By coimmunoprecipitation of overexpressed Cdk4 and cyclin 
D, we observed increased binding between Cdk4 and cyclin D1, D2 
under an OGT overexpressed condition.
In this research we aim to identify that G1/S cell cycle transition is 
regulated by the O-GlcNAcylation on Cdk4, which increases the binding 
between Cdk4 and cyclin D. Such relationship serve to show that 
increased global O-GlcNAcylation of cancer cells contribute to cancer 
cell proliferation.
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Chapter 1. Introduction
O-GlcNAcylation is a single sugar modification occurring on serine 
and threonine of proteins. It is also a post-translational modification 
occurring on proteins in the cytosol and nucleus of a cell (Fig. 1). The 
O-GlcNAc is attached by O-GlcNAc transferase (OGT) and removed by 
O-GlcNAcase (OGA)[1]. UDP-GlcNAc, a substrate for O-GlcNAcylation, 
is synthesized through the hexosamine biosynthetic pathway (HBP). For 
this reason O-GlcNAcylation is regarded as a nutrient sensor indicating 
cellular nutrient conditions [2,3]. O-GlcNAcylation can regulate a 
multitude of intercellular protein functions, either individually or in 
interplay with O-phosphorylation [1,4], and is linked to diseases such as 
cancer, diabetes and Alzheimer's disease [4,5].
Figure 1. The regulation of O-GlcNAcylation
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Naturally, the relationship between cancer and O-GlcNAcylation has 
been studied for a long time. A common point in these research was 
that cancer cells possessed a higher level of global O-GlcNAcylation 
compared to normal cells [6]. This phenomenon has been reported in 
prostate [7], primary colorectal [8], breast [9], lung and colon cancer 
[10]. Therefore, we hypothesized that high O-GlcNAcylation conditions 
positively influence cancer cell proliferation.
From here we took the cell cycle into consideration as an influential 
factor in cancer proliferation. Cell cycle directly regulates cell 
proliferation of not only cancer cells, but all cells. Further, studies have 
shown that O-GlcNAcylation is involved in the regulation of whole cell 
cycle [11]. However, the relationship between O-GlcNAcylation and G1/S 
phase as not yet been studied in depth.
Using lung cancer cell line, we discovered that decreasing cancer 
cell O-GlcNAcylation by OGT knock-down resulted in a delay in cell 
G1/S transition. And by Western blot, we determined that this delay was 
caused by pRB hypophosphorylation. Furthermore we identified that 
cyclin-dependent kinase 4 (Cdk4), a crucial protein in G1/S transition, is 
O-GlcNAcylated. This modification is regulated during G1/S cell cycle 
transition. Lastly upon overexpression of OGT, we observed increased 
binding of Cdk4 and cyclin D which is crucial to pRB phosphorylation 
and G1/S cell cycle transition. Such result confirmed the possible 
functional property of O-GlcNAcylation on Cdk4.
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Chapter 2. Materials and Methods
2.1 Cell culture
HEK293 (tumorized human embryonic kindney cell), A549 (human 
lung adenocarcinoma epithelial cell) cell lines were cultured in High 
Glucose DMEM (Dulbecco’s Modified Eagle’s Medium, HyCloneTM) 
supplemented with 10% FBS (Fetal Bovine Serum, HyCloneTM) and 1% 
P/S (Penicilline/Streptomycin, HyCloneTM) in 5% CO2 at 37℃.
2.2 DNA plasmids and transfection
cDNA of human full-length Cdk4, cyclin D1, cyclin D2, cyclin D3 
were generated by PCR and cloned into the p3XFLAG-CMVTM-7.1 
expression vector (Sigma Aldrich). FLAG-Cdk4 was subcloned into the 
pEXPR-IBA105 One-Strep tag vector (IBA). Untagged OGT was used for 
OGT overexpression [12]. The sequences of all constructs were checked 
by DNA sequencing. These DNA plasmids were transfected into cells 
using polyethylenimine (PEI, Sigma Aldrich).
2.3 Establishment of OGT knock-down stable cell line
For establishment of stable OGT knock-down cells, lentiviral clones 
expressing shOGT were acquired from Sigma Aldrich. Lentiviruses were 
produced in 293FT cells with Lipofectamine 2000 (Invitrogen) and 
infected into A549 cells according to the manufacturer's directions. The 
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stable clones were selected via puromycin (5μg/ml) treatment (shOGT). 
Non-target shRNA lentiviral transduction particles (Sigma Aldrich) were 
used as a negative control (shCTL).
2.4 Synchronization of cell culture
Cell cycle synchronization was achieved by serum deprivation 
experiments. A549 cells were washed twice with PBS and cultured in 
serum-free media for 48hr. To release the cell cycle block, cells were 
grown in the presence of 10% FBS and harvested at the indicated time 
periods.
2.5 FACS analysis
For flow cytometric analysis of the cell cycle, FACS analysis was 
performed by staining DNA with propidium iodide (PI). A549 cells treated 
as described above were washed in PBS and harvested using trypsin. 
After centrifugation at 3,000rpm for 3min, the cell pellet was washed 
with PBS and fixed in 70% (v/v) ice-cold ethanol at –20℃ for 3h. Cells 
were centrifugated, washed with PBS, and then incubated with 50μg/ml 
PI (Sigma Aldrich) and 20μg/ml RNAse A (Sigma Aldrich) at 37℃ for 
30min. After washing with PBS, flow cytometric analysis was performed 
on a FACScalibur (Becton Dickinson) instrument using the associated 
CellQuestTM software package (Becton Dickinson). The distribution of 
cells in the different phases of the cell cycle was analysed by 
appropriate software (ModFit LT; Becton Dickinson).
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2.6 Cell lysis, SDS-PAGE, and Western blot
Cells were lysed on ice for 30min in NET buffer [150mM NaCl, 
50mM Tris-HCl, 1% NP-40, 1mM EDTA and protease inhibitor cocktail 
(Roche Appled Science)] and centrifuged at 13,900rpm for 20min. 
Protein concentration of the supernatant was measured by Bradford 
Assay using Protein Assay Dye Reagent Concentrate (BIO-RAD). The 
lysates were boiled in 4x SDS sample buffer. The samples were 
separated by SDS-PAGE using 10~12% polyacrylamide gel and 
transferred onto nitrocellulose membranes (GE Healthcare). The 
membranes were incubated in 5% skin milk for 1hr at room temperature 
and washed 3 times with TBS-T. After washing, the membranes were 
incubated in primary antibodies diluted in TBS-T for 16hr at 4℃ and 
washed 3 times with TBS-T. They were incubated in secondary 
antibodies diluted in TBS-T for 1hr at room temperature, and washed 3 
times with TBS-T. Immunoreactive bands were detected using an ECL 
system (GE Healthcare, Bio-Science).
2.7 Succinylated wheat germ agglutinin (sWGA) precipitation
For sWGA precipitation, cell lysates were incubated with 
agarose-sWGA (Vector Lab) at 4℃ overnight. After washing 4 times with 
lysis buffer, precipitates were eluted in 2x SDS sample buffer.
2.8 Immunoprecipitation
For FLAG immunoprecipitation, cell lysates were incubated with 
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EzviewTM Red anti-FLAG M2 Affinity Gel (Sigma Aldrich) at 4℃ overnight. 
After washing 4 times with lysis buffer, precipitates were eluted in 2x 
SDS sample buffer.
The One-strep tag system is a method which allows the purification 
and detection of proteins by affinity chromatography. The One-strep tag 
is a synthetic peptide consisting of 8 amino acids 
(Trp-Ser-His-Pro-Gln-Phe-Glu-Lys). This peptide sequence exhibits 
intrinsic affinity towards Strep-Tactin, a specifically engineered 
streptavidin and can be N- or C- terminally fused to recombinant 
proteins. Streptavidin is a tetrameric protein expressed in Streptomyces 
avidinii. Because of its high affinity for the vitamin h-biotin, streptavidin 
is commonly used in the fields of molecular biology and biotechnology 
(Wikipedia).
For One-strep immunoprecipitation, cell lysates were incubated with 
Strep-Tactin Sepharose (IBA) at 4℃ overnight. After washing 4 times 
with lysis buffer, precipitates were eluted in 2x SDS sample buffer.
2.9 Antibodies
The following primary antibodies were used: α-O-GlcNAc (CTD110.6, 
MMS-248R, Covance), α-OGT (DM-17, O5264, Sigma Aldrich), α-OGT 
(TI-17, O6014, Sigma Aldrich), α-Cdk4 (H-22, sc-601, Santa Cruz 
Biotechnology), α-cyclin D1 (M-20, sc-718, Santa Cruz Biotechnology), 
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α-phospho-Ser807/811-pRB (8516S, Cell Signaling), α-One-strep 
(2-1507-001, IBA), α-FLAG (F7425, Sigma Aldrich), α-GAPDH (MAB374, 
Millipore).
The secondary antibodies conjugated to HRP (Horse radish 
peroxidase) were purchased from Santa Cruz Biotechnology (α-mouse 
IgG; sc-2005, α-rabbit IgG; sc-2004, α-mouse IgM; sc-2064).
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Chapter 3. Results
3.1 Decreased OGT level delays G1/S cell cycle transition via 
pRB hypophosphorylation in human lung cancer cell
To observe how cancer cell G1/S transition is changed when cancer 
cell O-GlcNAcylation level is decreased, we generated an OGT 
knock-down stable cell line (shOGT) and control cell line (shCTL) from 
A549 lung cancer cell line (Fig. 2A). We subjected the two cell lines to 
serum deprivation in order to synchronize cells to the G0/G1 phase. 
After releasing cells by adding serum to media, the change in cell cycle 
phase of cells according to time points was analyzed using FACS 
analysis (Fig. 2B). When the ratio of cells in S phase was plotted 
against time in graph we found that the increase in number of cells in 
the S phase was slower for shOGT cells compared to shCTL cells (Fig 
2D).
There are several restriction points that are required for a cell to 
transition from G1 to S phase. Of these, pRB phosphorylation by 
Cdk4-cyclin D complex is an event which occurs at an early stage [13, 
14](Fig. 3). To determine the cause of the G1/S phase transition delay 
observed previously, we checked how pRB phosphorylation changed 
according to time using the same two cell lines. In the Western blot 
experiment using phospho-pRB antibody, shOGT cells exhibited 
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hypophosphorylated pRB for serine 807 and 811 according to 
progression of time when compared to shCTL cells (Fig. 4). From these 
experiments we concluded that global decrease of O-GlcNAcylation 
induced by knock-down of OGT in lung cancer cells delayed G1/S 
phase transition through pRB hypophosphorylation.
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Figure 2. Decreased OGT level delays G1/S cell cycle 
transition in A549 cells. (A) OGT level was decreased by shRNA in 
A549 cells (shOGT). Non-targeted shRNA was used as a negative 
control (shCTL). (B) Cells were synchronized by serum deprivation for 
48hr. After releasing by serum addition, cells were harvested at the 
indicated time points. harvested cells were analyzed by FACS machine. 
(C) FACS results were digitized by ModFit LT software. (D) The cells in 
S phase were displayed in graph form.
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Figure 3. pRB phosphorylation by Cdk4 and cyclin D complex
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Figure 4. Decreased OGT level causes pRB 
hypophosphorylation in A549 cells. A comparison was made 
between shOGT and shCTL. Cells were synchronized by serum 
deprivation, and released. (A) Harvested cells with indicated time points 
were analyzed by SDS-PAGE and Western blot with phospho-pRB 
antibodies (S807/811). (B) Quantified phospho-pRB (S807/811) values 
are displayed in graph form.
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3.2 Cyclin-dependent kinase 4 (Cdk4) is O-GlcNAcylated, 
and this modification is regulated during G1/S cell cycle 
transition
In order to identify the protein involved in decreased 
O-GlcNAcylation, delayed G1/S phase transition, and hypophosphorylated 
pRB, we examined whether Cdk4, which is directly involved in pRB 
phosphorylation [13,15], is O-GlcNAcylated. When OGT and 
FLAG-tagged Cdk4 were overexpressed in HEK293 cells, 
O-GlcNAcylation was detected on Cdk4. In proportion to the increased 
amount of overexpressed OGT, the amount of detected O-GlcNAcylation 
was also found to increase dose dependently (Fig. 5).
To see whether O-GlcNAcylation on Cdk4 is regulated during cell 
G1/S transition, A549 cells were synchronized and released as described 
previously. The prepared cells were then used in lectin precipitation with 
sWGA which binds the O-GlcNAc moiety of proteins. The obtained 
samples were used in Western blot and probed for Cdk4 using the Cdk4 
antibody. We discovered that after cell release, the detected Cdk4 blot 
increased and then decreased over time (Fig. 6). It means 
O-GlcNAcylation on Cdk4 is regulated during G1/S cell cycle transition. 
Since it is known that the time point when cyclin D1 is maximized 
correlates with pRB phosphorylation and G1/S transition progression 
[16]. Our result also indicated the possibility that O-GlcNAcylation on 
Cdk4 could influence cell G1/S transition progress.
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Figure 5. Cdk4 is O-GlcNAcylated. FLAG-tagged Cdk4 
(FLAG-Cdk4) was overexpressed in HEK293 cells together with untagged 
OGT (3, 6, 10μg). After immunoprecipitation with FLAG affinity gel, 
O-GlcNAcylated FLAG-Cdk4 was immunoblotted.
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Figure 6. O-GlcNAcylation on Cdk4 is regulated during G1/S 
cell cycle transition. A549 cells were synchronized by serum 
deprivation, released, and harvested cells at indicated time points. 
Endogenous Cdk4 was precipitated with sWGA. Cdk4 precipitated with 
sWGA, total Cdk4, GAPDH, and cyclin D1 were immunoblotted.
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3.3 OGT overexpression enhances protein-protein interaction 
between Cdk4 and cyclin D
Based upon the results in Fig. 6, it was shown that the level of 
O-GlcNAcylation on Cdk4 and the amount of cyclin D was maximized at 
the same point of time. Thus we hypothesized that O-GlcNAcylation on 
Cdk4  may affect the binding between Cdk4 and cyclin D. To confirm 
this, HEK293 cells were transfected with One-strep-tagged Cdk4 and 
FLAG-tagged cyclin D1 together. Using the transfected cells we carried 
out immunoprecipitation using One-strep affinity gel. The amount of 
cyclin D1 bound to Cdk4 was detected in Western blot using FLAG 
antibody. As a result we found that under OGT overexpressed condition, 
more cyclin D1 was detected compared to when OGT was not 
overexpressed (Fig. 7). Since there are three kinds of cyclin D (cyclin 
D1, D2 and D3), the same immunoprecipitation experiment was carried 
out for cyclin D2 and D3. In case of cyclin D2, OGT overexpression 
resulted in increased cyclin D2 detection as in the case of cyclin D1 
(Fig. 8). However in the case of cyclin D3, OGT overexpression did not 
result in a change of amount of detected cyclin D3 (Fig. 9). Therefore 
we concluded that OGT overexpression, which increases 
O-GlcNAcylation on proteins including Cdk4, promotes binding between 
Cdk4 and cyclin D1, D2.
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Figure 7. OGT overexpression enhances protein binding 
between Cdk4 and cyclin D1. One-strep-tagged Cdk4 (One-strep- 
Cdk4) and FLAG-tagged cyclin D1 (FLAG-cyclin D1) were overexpressed 
in HEK293 with or without OGT overexpression. After immunoprecipitation 
with One-strep affinity gel, precipitated cyclin D1 and Cdk4 were 
immunoblotted.
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Figure 8. OGT overexpression enhances protein binding 
between Cdk4 and cyclin D2. One-strep-tagged Cdk4 (One-strep- 
Cdk4) and FLAG-tagged cyclin D2 (FLAG-cyclin D2) were overexpressed 
in HEK293 with or without OGT overexpression. After immunoprecipitation 
with One-strep affinity gel, precipitated cyclin D2 and Cdk4 were 
immunoblotted.
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Figure 9. OGT overexpression has no effect on protein 
binding between Cdk4 and cyclin D3. One-strep-tagged Cdk4 
(One-strep-Cdk4) and FLAG-tagged cyclin D3 (FLAG-cyclin D3) were 
overexpressed in HEK293 with or without OGT overexpression. After 
immunoprecipitation with One-strep affinity gel, precipitated cyclin D3 
and Cdk4 were immunoblotted.
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Chapter 4. Discussion
Considering that O-GlcNAcylation is a cellular nutrient sensor [17,1
8], it is natural to come to the conclusion that it will affect cell 
proliferation and its crucial cell cycle regulation. This is supported by 
studies on the function of O-GlcNAcylation in relation to the cell cycle 
[11]. Furthermore, as cancer cells commonly exhibit elevated global 
O-GlcNAcylation [6-10], we can speculate that O-GlcNAcylation has a 
cell proliferation promoting function. This study too shows that 
O-GlcNAcylation is  actively involved in cell cycle regulation.
There were several limitations throughout this research. First, 
although it was confirmed that pRB was hypophosphorylated and G1/S 
transition was delayed by OGT knock-down, following the release of 
synchronized cells initially showed more S phase cells in the OGT 
knock-down cells than in control cells. In addition, pRB phosphorylation 
also appeared earlier in OGT knockdown cells. This phenomenon 
requires further explanation through follow up studies.
Second, in sWGA precipitation, O-GlcNAcylated proteins and other 
proteins interacting with the modified proteins can both be precipitated. 
Thus we cannot simply consider all bands detected in Western blot as 
O-GlcNAcylated proteins. From Fig. 6, we can just conclude that 
O-GlcNAcylation on Cdk4 or O-GlcNAcylated binding partners of Cdk4 
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are regulated during G1/S phase transition. To get more restricted 
conclusion, further experiments such as Cdk4 immunoprecipitation are 
needed.
Third, though the binding of Cdk4 and cyclin D is increased upon 
OGT overexpression, it does not mean that increased binding with cyclin 
D is due to the increase of O-GlcNAcylation on Cdk4. This is because 
OGT overexpression does not increase only O-GlcNAcylation on Cdk4, 
but also the O-GlcNAcylation of other proteins. Thus this results must 
be further proved by in vitro binding assays such as GST pull-down 
assay.
A possible explanation regarding the lack of change in the binding 
of Cdk4 and cyclin D3 may be because of the difference in structure 
between cyclin D3 and the other two proteins (cyclin D1, D2). It is 
known that while the cyclin D family are homologous proteins with the 
same function, they are not spliced variants but proteins originating from 
separate genes [19]. Two recent publications describing the binding 
structures of Cdk4-cyclin D1 [20] and Cdk4-cyclin D3 [21] also give 
weight to this hypothesis.
Regardless of these limitations this research provides a novel 
understanding of the relationship between cancer and O-GlcNAcylation, 
and the connection between O-GlcNAcylation and G1/S phase transition 
with Cdk4 as intermediate. To further this study there is a need to 
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identify the O-GlcNAcylated sites of Cdk4 using mass spectrometry and 
point mutation. Following that, Cdk4-cyclin D binding experiments using 
the O-GlcNAcylated sites mutated Cdk4, make it more reliable that 
O-GlcNAcylation on Cdk4 acts directly upon the binding between Cdk4 
and cyclin D.
Moreover, by generating wild type Cdk4 or O-GlcNAcylated sites 
mutated Cdk4 expressing cell lines from A549, it will be possible to 
observe delays in G1/S phase transition and pRB phosphorylation in 
those mutant expressing cell lines. Thus we can unveil the importance of 
O-GlcNAcylation on Cdk4 in delayed cancer cell G1/S transition upon 
global O-GlcNAcylation decrease.
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Summary
1. When OGT level is decreased, G1/S cell cycle transition is delayed.
2. Decreased OGT level causes pRB hypophosphorylation. 
3. Cdk4 protein is O-GlcNAcylated, and this O-GlcNAcylation is 
up-regulated during G1/S cell cycle transition.
4. OGT overexpression enhances protein binding between Cdk4 and 
cyclin D1, D2.
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국문 요약
O-GlcNAcylation은 핵과 세포질 내에서 단백질에 일어나는 번역 후 수식
화 중 하나이다. 이 수식화는 단백질의 발현과 기능을 조절하여, 세포 내 다
양한 대사와 신호 전달에 관여하고 있다. 이 수식화의 O-GlcNAc 주개인 
UDP-GlcNAc은 포도당으로부터 hexosamine biosynthetic pathway (HBP)를 
통해 합성되며, 그 합성은 세포의 포도당 농도 환경에 크게 영향을 받는다. 
또한, O-GlcNAcylation은 암, 당뇨, 알츠하이머 병 등 다양한 질병들에도 관
여하고 있음이 알려져 있다.
암세포가 정상세포에 비해 높은 O-GlcNAcylation 상태를 가지며, 
O-GlcNAcylation이 세포 주기 조절에 관여하고 있다는 여러 보고에 따라, 우
리는 암세포의 높은 O-GlcNAcylation이 세포 주기 전환을 촉진한다는 가설을 
세웠다. 그것을 확인하기 위해, 폐암 세포주인 A549를 가지고 OGT가 감소된 
안정 세포주를 만들었다. FACS 분석를 통해 이 세포들의 G1/S 세포 주기 전
환이 상대적으로 느려진 것을 확인하였다. 그리고 Western blot을 통해 이러
한 G1/S기 전환 저해가 pRB 단백질의 인산화 감소로 인한 것임을 확인하였
다.
O-GlcNAcylation 감소와 pRB의 인산화 감소 간의 연관성을 더 깊이 이
해하기 위해, pRB의 인산화에 관련된 단백질인 cyclin-dependent kinase 4 
(Cdk4)가 O-GlcNAcylation 되는지 확인해보았다. Western blot을 통해, 과발
현된 Cdk4에서 O-GlcNAcylation이 탐지되는 것을 확인하였고, 그것이 OGT
를 과발현시켰을 때 더 증가하는 것을 확인하였다. 또한, 단백질의 O-GlcNAc 
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부분와 결합하는 sWGA 렉틴 침강법을 이용해, 세포의 G1/S기 전환동안 
Cdk4의 O-GlcNAcylation이 조절되는 것도 확인하였다.
이러한 Cdk4의 O-GlcNAcylation이 가지는 기능을 밝히기 위해, G1/S기 
전환에 있어서 핵심적인 역할을 하는 Cdk4와 cyclin D의 결합에 초점을 맞추
었다. 과발현된 Cdk4와 cyclin D의 공동 면역침강법을 통해, OGT를 과발현
시켰을 때 Cdk4와 cyclin D1, D2 간의 결합이 증가하는 것을 확인하였다. 이
번 연구를 통해, 우리는 G1/S 세포 주기 전환이 Cdk4의 O-GlcNAcylation에 
의해 조절되며, 이 수식화가 Cdk4와 cyclin D의 결합을 증가시킨다는 것을 
밝힘으로써, 증가된 암세포의 O-GlcNAcylation이 암세포의 증식에 기여하는 
기작 중 하나를 제안하였다.
Keywords : O-GlcNAc, cancer cell, cell cycle, OGT, G1/S transition, pRB 
phosphorylation, Cdk4, cyclin D
